Karsten Quast
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Karsten Quast has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Andreas Weith
Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach/Riss, Germany
2 shared publications - Detlev Mennerich
Department of Pulmonary Research, Group Genomics, Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorferstraße 67, 88397 Biberach an der Riß, Germany and Department of Immunology and Inflammation, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT 06877-0368, USA
2 shared publications - Benedikt Brors
Division of Applied Bioinformatics, The German Cancer Research Center (DKFZ), Heidelberg, Germany
1 shared publication - Carina Ittrich
Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach/Riss, Germany
1 shared publication - Katrin Fundel-Clemens
Boehringer Ingelheim Pharma GmbH & Co. KG, Div. Research Department, 88400 Biberach, Germany
1 shared publication - Patrick Baum
Translational Medicine & Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany
1 shared publication
Latest Publications
- Open Access
- 2 June 2010
- Published by Springer Nature in BMC Genomics
- Vol. 11 (1) , 1-17
Comparison of normalization methods for Illumina BeadChip HumanHT-12 v3
Background: Normalization of microarrays is a standard practice to account for and minimize effects which are not due to the controlled factors in an experiment. There is an overwhelming number of different methods that can be applied, none of which is ideally suited for all experimental designs. Thus, it is important to identify a normalization method appropriate for the experimental setup under consideration that is neither too negligent nor too stringent. Major aim is to derive optimal results from the underlying experiment. Comparisons of different normalization methods have already been conducted, none of which, to our knowledge, comparing more than a handful of methods.Results: In the present study, 25 different ways of pre-processing Illumina Sentrix BeadChip array data are compared. Among others, methods provided by the BeadStudio software are taken into account. Looking at different statistical measures, we point out the ideal versus the actual observations. Additionally, we compare qRT-PCR measurements of transcripts from different ranges of expression intensities to the respective normalized values of the microarray data. Taking together all different kinds of measures, the ideal method for our dataset is identified.Conclusions: Pre-processing of microarray gene expression experiments has been shown to influence further downstream analysis to a great extent and thus has to be carefully chosen based on the design of the experiment. This study provides a recommendation for deciding which normalization method is best suited for a particular experimental setup.
- 2 June 2010
- Published by Springer Nature in BMC Genomics
- Vol. 11 (1) , 1-17
Open AccessComparison of normalization methods for Illumina BeadChip HumanHT-12 v3
Background: Normalization of microarrays is a standard practice to account for and minimize effects which are not due to the controlled factors in an experiment. There is an overwhelming number of different methods that can be applied, none of which is ideally suited for all experimental designs. Thus, it is important to identify a normalization method appropriate for the experimental setup under consideration that is neither too negligent nor too stringent. Major aim is to derive optimal results from the underlying experiment. Comparisons of different normalization methods have already been conducted, none of which, to our knowledge, comparing more than a handful of methods.Results: In the present study, 25 different ways of pre-processing Illumina Sentrix BeadChip array data are compared. Among others, methods provided by the BeadStudio software are taken into account. Looking at different statistical measures, we point out the ideal versus the actual observations. Additionally, we compare qRT-PCR measurements of transcripts from different ranges of expression intensities to the respective normalized values of the microarray data. Taking together all different kinds of measures, the ideal method for our dataset is identified.Conclusions: Pre-processing of microarray gene expression experiments has been shown to influence further downstream analysis to a great extent and thus has to be carefully chosen based on the design of the experiment. This study provides a recommendation for deciding which normalization method is best suited for a particular experimental setup.
- Open Access
- 1 January 2008
- Published by Springer Nature in BMC Genomics
- Vol. 9 (1) , 91
Effect of RNA quality on transcript intensity levels in microarray analysis of human post-mortem brain tissues
Large-scale gene expression analysis of post-mortem brain tissue offers unique opportunities for investigating genetic mechanisms of psychiatric and neurodegenerative disorders. On the other hand microarray data analysis associated with these studies is a challenging task. In this publication we address the issue of low RNA quality data and corresponding data analysis strategies.
- 1 January 2008
- Published by Springer Nature in BMC Genomics
- Vol. 9 (1) , 91
Open AccessEffect of RNA quality on transcript intensity levels in microarray analysis of human post-mortem brain tissues
Large-scale gene expression analysis of post-mortem brain tissue offers unique opportunities for investigating genetic mechanisms of psychiatric and neurodegenerative disorders. On the other hand microarray data analysis associated with these studies is a challenging task. In this publication we address the issue of low RNA quality data and corresponding data analysis strategies.